Phibro Animal Health Corporation (PAHC) Financial Statements (2024 and earlier)

Company Profile

Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR
TEANECK, NJ 07666
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
MRQ
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:81,28191,24891,60191,34381,57379,168
Cash and cash equivalents41,28174,24850,21236,34357,57329,168
Short-term investments40,00017,00043,00055,00024,00050,000
Other undisclosed cash, cash equivalents, and short-term investments   (1,611)   
Receivables163,479166,537146,852126,522159,022135,742
Inventory, net of allowances, customer advances and progress billings277,570259,158216,312196,659198,322178,170
Inventory277,570259,158216,312196,659198,322178,170
Other current assets63,39349,28942,53337,31327,24522,381
Other undisclosed current assets   1,611   
Total current assets:585,723566,232498,909451,837466,162415,461
Noncurrent Assets
Property, plant and equipment195,568165,490154,706148,109140,235130,108
Intangible assets, net (including goodwill)108,261117,087114,961123,67674,82679,326
Goodwill53,27453,22652,67952,67927,34827,348
Intangible assets, net (excluding goodwill)54,98763,86162,28270,99747,47851,978
Other noncurrent assets81,84582,89072,74960,47845,44846,784
Total noncurrent assets:385,674365,467342,416332,263260,509256,218
TOTAL ASSETS:971,397931,699841,325784,100726,671671,679
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities124,024192,366154,741138,488141,687130,642
Taxes payable7,211    
Employee-related liabilities34,278    
Accounts payable73,85395,59668,36266,09173,18959,498
Accrued liabilities50,17155,28186,37972,39768,49871,144
Deferred revenue 370   
Debt22,29515,0009,37518,75012,54012,579
Other liabilities18,85918,904    
Other undisclosed current liabilities10,452(35,438)    
Total current liabilities:176,000190,832164,116157,238154,227143,221
Noncurrent Liabilities
Long-term debt and lease obligation, including:311,541417,925297,085368,257217,635229,802
Long-term debt, excluding current maturities311,541417,925382,710368,25796,00070,000
Other undisclosed long-term debt and lease obligation   (85,625) 121,635159,802
Liabilities, other than long-term debt72,49160,50061,67270,40149,88751,335
Deferred income tax liabilities 1,714   
Liability for uncertainty in income taxes 10,430 5,702 7,0937,633
Other liabilities60,34760,50055,97070,40142,79443,702
Other undisclosed noncurrent liabilities128,856 79,923 88,90762,367
Total noncurrent liabilities:512,888478,425438,680438,658356,429343,504
Total liabilities:688,888669,257602,796595,896510,656486,725
Equity
Equity, attributable to parent, including:282,509262,442238,529188,204216,015184,954
Additional paid in capital135,803135,803135,803135,525133,266129,873
Accumulated other comprehensive loss(114,210)(121,113)(115,293)(130,385)(86,181)(76,483)
Retained earnings260,912247,748218,015183,060168,926131,560
Other undisclosed equity, attributable to parent444444
Total equity:282,509262,442238,529188,204216,015184,954
TOTAL LIABILITIES AND EQUITY:971,397931,699841,325784,100726,671671,679

Income Statement (P&L) ($ in thousands)

12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
Revenues977,889942,261833,350800,354827,995819,982
Cost of revenue
(Cost of Goods and Services Sold)
(679,652)(656,861)(561,973)(543,472)(563,371)(553,103)
Gross profit:298,237285,400271,377256,882264,624266,879
Operating expenses(226,390)(206,414)(196,509)(187,688)(181,398)(167,953)
Operating income:71,84778,98674,86869,19483,22698,926
Nonoperating income (expense)
(Gain (Loss), Foreign Currency Transaction, before Tax)
(2,455)5,2164,480(826)551,054
Interest and debt expense(18,676)(12,691)(13,718)(14,613)(494)(537)
Income from continuing operations before equity method investments, income taxes:50,71671,51165,63053,75582,78799,443
Other undisclosed income (loss) from continuing operations before income taxes3,3558168381,757(11,282)(11,373)
Income from continuing operations before income taxes:54,07172,32766,46855,51271,50588,070
Income tax expense(21,465)(23,152)(12,083)(21,960)(16,792)(23,187)
Income from continuing operations:32,60649,17554,38533,55254,71364,883
Income before gain (loss) on sale of properties:49,17554,38533,55254,71364,883
Net income available to common stockholders, diluted:32,60649,17554,38533,55254,71364,883

Comprehensive Income ($ in thousands)

12/31/2023
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
Net income:32,60649,17554,38533,55254,71364,883
Other comprehensive income (loss)1,2305,195(1,478)   
Other undisclosed comprehensive income      
Comprehensive income:33,83654,37052,90733,55254,71364,883
Other undisclosed comprehensive income (loss), net of tax, attributable to parent5,673(11,015)16,570(44,204)(9,698)(21,046)
Comprehensive income (loss), net of tax, attributable to parent:39,50943,35569,477(10,652)45,01543,837

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: